Northwest Biotherapeutics Company

Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.

Total Funding: 169400000
Headquarters: Bethesda, Maryland, United States
Funding Status: IPO
Employee Number: 11-50
Estimated Revenue: Less than $1M
Last Funding Type: Post-IPO Debt
Last Funding Date: 2021-11-22
Investors Number: 1
Founded Date: 1998-01-01
Industry: Dendritic Cells